“…Emerging evidence suggests a significant role for mitochondrial dysfunction, oxidative stress and inflammation as the main contributors to the neuronal damage that is observed in major depressive disorder (MDD) (Bakunina, Pariante, & Zunszain, ; Morris & Berk, ). On the other hand, antidepressants might decrease inflammatory and oxidative damage and improve mitochondrial dysfunction in animal models of depression (Réus, Abelaira, et al, ; Réus, Carlessi, et al, ) and in depressed patients (Behr, Moreira, & Frey, ; Lee et al, ). Furthermore, current antidepressants have major shortcomings that include slow onset of action, poor efficacy and unwanted side effects, the search for new and improved antidepressants is still relevant (El‐Alfy, Abourashed, & Matsumoto, ).…”